Navigating the immune landscape with plasma cells: A pan‐cancer signature for precision immunotherapy
BioFactors · 2025
DOI: 10.1002/biof.2142 ↗Kurz gefasst
Fachartikel in der Zeitschrift BioFactors, 2025. Verfasst von Bicheng Ye und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Clinical Medicine, Yangzhou Polytechnic College, Yangzhou, China. Hauptthemen laut MEDLINE: Immunotherapy, Neoplasms, Tumor Microenvironment, Plasma Cells. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 64 Literaturangaben. Gefördert von: The Excellent Teaching Team Fund of the Qinglan Project at Yangzhou Polytechnic College, The Jiangsu Province Qinglan Project for Academic Leaders among Young and Middle-Aged Scholars.
Abstract (Originalsprache)
Immunotherapy has revolutionized cancer treatment; however, predicting patient response remains a significant challenge. Our study identified a novel plasma cell signature, Plasma cell.Sig, through a pan‐cancer single‐cell RNA sequencing analysis, which predicts patient outcomes to immunotherapy with remarkable accuracy. The signature was developed using rigorous machine learning algorithms and validated across multiple cohorts, demonstrating superior predictive power with an area under the curve (AUC) exceeding 0.7. Notably, the low‐risk group, as classified by Plasma cell.Sig, exhibited enriched immune cell infiltration and heightened tumor immunogenicity, indicating an enhanced responsiveness to immunotherapy. Conversely, the high‐risk group showed reduced immune activity and potential mechanisms of immune evasion. These findings not only enhance understanding of the intrinsic and extrinsic immune landscapes within the tumor microenvironment but also pave the way for more precise, biomarker‐guided immunotherapy approaches in oncology.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Clinical Medicine, Yangzhou Polytechnic College, Yangzhou, China.
- Department of Urology, Changhai Hospital, Naval Medical University (Second Military Medical University), Shanghai, China.
- Department of Gastroenterology, Huai'an Second People's Hospital, The Affiliated Huai'an Hospital of Xuzhou Medical University, Huai'an, Jiangsu, China.
- Chongqing Key Laboratory of Molecular Oncology and Epigenetics, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Department of Lung Cancer, Tianjin Lung Cancer Center, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin Medical Univer…
ORCID-Profile: Bicheng Ye, Xiaoqing Liang, Pengpeng Zhang
Förderung
- The Excellent Teaching Team Fund of the Qinglan Project at Yangzhou Polytechnic College
- The Jiangsu Province Qinglan Project for Academic Leaders among Young and Middle-Aged Scholars
Zitieren
APA
Ye, B., Jiang, A., Liang, F., Wang, C., Liang, X., & Zhang, P. (2025). Navigating the immune landscape with plasma cells: A pan‐cancer signature for precision immunotherapy. BioFactors. https://doi.org/10.1002/biof.2142
Vancouver
Ye B, Jiang A, Liang F, Wang C, Liang X, Zhang P. Navigating the immune landscape with plasma cells: A pan‐cancer signature for precision immunotherapy. BioFactors. 2025. doi:10.1002/biof.2142
BibTeX
@article{Ye2025,
author = {Ye, Bicheng and Jiang, Aimin and Liang, Feng and Wang, Changcheng and Liang, Xiaoqing and Zhang, Pengpeng},
title = {Navigating the immune landscape with plasma cells: A pan‐cancer signature for precision immunotherapy},
journal = {BioFactors},
year = {2025},
doi = {10.1002/biof.2142}
}
EUVIMED